We found that GPNMB+ microglia showed the same robust and statistically significant association (higher abundance) in the DLPFC in these two published studies, in individuals with a clinical diagnosis of MCI or Alzheimer’s dementia, and with steeper slope of cognitive decline (Fig. 4B). Here, GPNMB is linked to Alzheimer disease.